Piperidine

Piperidine

SCHEMBL8000110

B.B.B.C1CCNCC1.C1CNCCN1.c1ccncc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CXCR4 P61073 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CHRNB2 P17787 2/20 0.37
CHRNA4 P43681 2/20 0.37
ADRB2 P07550 1/20 0.31
NCF1 P14598 1/20 0.31
PLD1 Q13393 1/20 0.31
HIF1A Q16665 1/20 0.30
MAPT P10636 1/20 0.30
PDE4A P27815 1/20 0.30
KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL28040221 0.97 ALDH1A1 (0.47) ALDH1A1TSHRNAPRTTDP1CXCR4
Piperidine SCHEMBL27535943 0.97 ALDH1A1 (0.47) ALDH1A1TSHRNAPRTTDP1CXCR4
Piperidine SCHEMBL2420379 0.95 ALDH1A1 (0.50) ALDH1A1TSHRNAPRTTDP1CXCR4
Pyridine SCHEMBL812392 0.92 TSHR (0.53) ALDH1A1TSHRNAPRTTDP1CXCR4
Pyridine SCHEMBL28057559 0.90 TSHR (0.50) ALDH1A1TSHRNAPRTTDP1CXCR4
Pyridine SCHEMBL5210014 0.90 CXCR4 (0.50) ALDH1A1TSHRNAPRTTDP1CXCR4
Pyridine SCHEMBL8406615 0.90 CXCR4 (0.50) ALDH1A1TSHRNAPRTTDP1CXCR4
Piperazine SCHEMBL28224527 0.87 TSHR (0.53) ALDH1A1TSHRNAPRTTDP1CXCR4
Piperazine SCHEMBL1699696 0.87 TSHR (0.60) ALDH1A1TSHRNAPRTTDP1CXCR4
Pyridine SCHEMBL21497058 0.87 TSHR (0.60) ALDH1A1TSHRNAPRTTDP1CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979208-A4 COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER MORTON INT INC (US) 2000-10-25 EP disclosed
EP-0979208-A1 COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER MORTON INTERNATIONAL, INC. (US) 2000-02-16 EP disclosed
WO-1999042402-A1 COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER MORTON INTERNATIONAL, INC. (US) 1999-08-26 WO disclosed